Research Participants

Subjects come first for the BRANY Institutional Review Board (IRB). We are dedicated to protecting the rights and ensuring the welfare of all human research subjects, as evidenced by our commitment to ethical research and rigorous research oversight.

This section of our website provides current and potential research participants with useful information about participating in clinical trials, the protections they are entitled to, and a method to provide feedback and concerns about specific clinical trials.


Search Trials

Our Newest Trials

Platinum-Resistant Ovarian Cancer

Breast Cancer

PD-L1 Positive Metastatic Triple-Negative Breast Cancer

Urothelial Carcinoma of the Bladder


Pediatric Patients with Cardiomyopathy due to MYBPC3 Mutations

Non-small Cell Lung Cancer

Upper Limb Essential Tremor

ECP Study

Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (C/SLL) or Non-Hodgkin Lymphoma (NHL)